在胃肠道癌症中承诺复杂的拼接因素 - - 一个在的研究
Yun Zhang1, Alexandria Carrasquillo Simko2, Uzondu Okoro1
1Department of Pharmaceutical Sciences, Texas Southern University, Houston, TX, USA.
Bioinformatics and biology insights
|October 18, 2024
概括
在胃肠道癌症中,结合体承诺复合体 (CC) 组件的变化很常见. 降低CC表达可能会改善结肠癌患者的生存率.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 生物信息学是一种生物信息学.
背景情况:
- 剪接体承诺复合体 (CC) 对于通过识别外子-内子边界来启动前mRNA剪接至关重要.
- 关键的CC组件包括U1 snRNP,SF1,U2AF1,U2AF2和PRP40,它们在拼接地点组装.
- 了解癌症中的CC变化对于确定新的治疗点至关重要.
研究的目的:
- 为了研究结合体承诺复合体 (CC) 组件缺陷对胃肠道 (GI) 癌症的影响.
- 分析CC因子的变化及其与各种胃肠道癌症患者结果的相关性.
- 确定CC的拼接目标及其相关途径.
主要方法:
- 对人类肠道癌患者组织的分析和cBioPortal的临床数据.
- 检查CC因子遗传变化和GI癌症的表达水平.
- 利用协同表达数据集来确定CC拼接目标,并进行路径分析.
主要成果:
- 虽然遗传变化很少发生 (1% - 13%),但结合表达变化在肠道癌中显示出高CC成分变化 (> 30%).
- 患有BRAF突变的结肠癌患者显示高CC变异频率 (19%-61%),与患有APC,KRAS或TP53突变的患者不同.
- CC基因的突变与有利的生存率相关,表明受损的CC表达有利于患者的生存.
结论:
- 在分析中有效确定了肠道癌症中结合体CC的分子功能.
- 高CC表达与更差的生存率有关,而较低的CC水平与更好的结果有关.
- 旨在降低CC水平的治疗策略可能会提高结肠癌患者的生存率.
相关概念视频
RNA Splicing
56.1K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.1K
Alternative RNA Splicing
21.0K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.0K
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Pre-mRNA Processing: RNA Splicing
5.2K
5.2K


